XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2
UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Cash Flows from Operating Activities:        
Net income     $ 9,723,517 $ 2,822,004
Adjustments to reconcile net income to net cash used in operating activities:        
Financing costs - derivative warrant liabilities       776,880
Change in fair value of derivative warrant liabilities $ (3,054,800) $ 5,455,000 (10,037,200) (4,582,200)
Change in fair value of promissory note - related party 36,034   (7,063)  
Interest income from investments held in trust account (392,020) (4,194) (414,547) (7,869)
Changes in operating assets and liabilities:        
Accounts payable     (120,679) 371,869
Accrued expenses     55,034 (14)
Prepaid expenses     206,325 (739,236)
Net cash used in operating activities     (594,613) (1,358,566)
Cash Flows from Investing Activities:        
Principal deposited in trust account       (276,000,000)
Net cash used in investing activities       (276,000,000)
Cash Flows from Financing Activities:        
Repayment of note payable to related parties       (280,000)
Proceeds from working capital loan     638,884  
Proceeds received from initial public offering, gross       276,000,000
Proceeds received from private placement       8,020,000
Offering costs paid     (70,000) (5,426,316)
Net cash provided by financing activities     568,884 278,313,684
Net change in cash     (25,729) 955,118
Cash - beginning of the period     132,241 111,696
Cash - end of the period $ 106,512 $ 1,066,814 $ 106,512 1,066,814
Supplemental disclosure of noncash investing and financing activities:        
Offering costs included in accrued expenses       70,000
Deferred underwriting commissions in connection with the initial public offering       $ 9,660,000